Global Real World Evidence Solutions Industry

Global Real World Evidence Solutions Market to Reach US$1. 9 Billion by the Year 2027. Amid the COVID-19 crisis, the global market for Real World Evidence Solutions estimated at US$770. 8 Million in the year 2020, is projected to reach a revised size of US$1.

New York, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Real World Evidence Solutions Industry" - https://www.reportlinker.com/p05959864/?utm_source=GNW
9 Billion by 2027, growing at a CAGR of 13.7% over the period 2020-2027.Data Sets, one of the segments analyzed in the report, is projected to grow at a 14.3% CAGR to reach US$1.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 12.4% CAGR for the next 7-year period. This segment currently accounts for a 32% share of the global Real World Evidence Solutions market.

The U.S. Accounts for Over 29.6% of Global Market Size in 2020, While China is Forecast to Grow at a 13.2% CAGR for the Period of 2020-2027

The Real World Evidence Solutions market in the U.S. is estimated at US$227.8 Million in the year 2020. The country currently accounts for a 29.55% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$329.8 Million in the year 2027 trailing a CAGR of 13.2% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.2% and 11.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10% CAGR while Rest of European market (as defined in the study) will reach US$329.8 Million by the year 2027.We bring years of research experience to this 8th edition of our report. The 181-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

• Anthem, Inc.

• Clinigen Group Plc

• Cognizant Technology Solutions Corporation

• IBM Corporation

• ICON PLC

• IQVIA

• Optum, Inc.

• Oracle Corporation

• Parexel International Corporation

• PerkinElmer, Inc.

• Pharmaceutical Product Development LLC

• SAS Institute, Inc.

• Syneos Health

Read the full report: https://www.reportlinker.com/p05959864/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Global Competitor Market Shares
Real World Evidence Solutions Competitor Market Share Scenario
Worldwide (in %): 2018E

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Real World
Evidence Solutions by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2018 through 2027

Table 2: World Historic Review for Real World Evidence
Solutions by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 3: World 15-Year Perspective for Real World Evidence
Solutions by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2012, 2018 & 2027

Table 4: World Current & Future Analysis for Data Sets by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2018 through 2027

Table 5: World Historic Review for Data Sets by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2017

Table 6: World 15-Year Perspective for Data Sets by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2018 & 2027

Table 7: World Current & Future Analysis for Services by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2018 through 2027

Table 8: World Historic Review for Services by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2017

Table 9: World 15-Year Perspective for Services by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2018 & 2027

Table 10: World Current & Future Analysis for Pharmaceutical &
Medical Device Companies by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2018 through 2027

Table 11: World Historic Review for Pharmaceutical & Medical
Device Companies by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 12: World 15-Year Perspective for Pharmaceutical &
Medical Device Companies by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World for Years 2012, 2018 & 2027

Table 13: World Current & Future Analysis for Healthcare Payers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2018 through 2027

Table 14: World Historic Review for Healthcare Payers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2017

Table 15: World 15-Year Perspective for Healthcare Payers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2018 & 2027

Table 16: World Current & Future Analysis for Healthcare
Providers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2018 through
2027

Table 17: World Historic Review for Healthcare Providers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2017

Table 18: World 15-Year Perspective for Healthcare Providers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2018 & 2027

Table 19: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2018 through 2027

Table 20: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2017

Table 21: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2018 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Real World Evidence Solutions Market Share (in %) by
Company: 2018 & 2027
Market Analytics
Table 22: USA Current & Future Analysis for Real World Evidence
Solutions by Component - Data Sets and Services - Independent
Analysis of Annual Sales in US$ Million for the Years 2018
through 2027

Table 23: USA Historic Review for Real World Evidence Solutions
by Component - Data Sets and Services Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 24: USA 15-Year Perspective for Real World Evidence
Solutions by Component - Percentage Breakdown of Value Sales
for Data Sets and Services for the Years 2012, 2018 & 2027

Table 25: USA Current & Future Analysis for Real World Evidence
Solutions by End-Use - Pharmaceutical & Medical Device
Companies, Healthcare Payers, Healthcare Providers and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2018 through 2027

Table 26: USA Historic Review for Real World Evidence Solutions
by End-Use - Pharmaceutical & Medical Device Companies,
Healthcare Payers, Healthcare Providers and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2017

Table 27: USA 15-Year Perspective for Real World Evidence
Solutions by End-Use - Percentage Breakdown of Value Sales for
Pharmaceutical & Medical Device Companies, Healthcare Payers,
Healthcare Providers and Other End-Uses for the Years 2012,
2018 & 2027

CANADA
Table 28: Canada Current & Future Analysis for Real World
Evidence Solutions by Component - Data Sets and Services -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 29: Canada Historic Review for Real World Evidence
Solutions by Component - Data Sets and Services Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 30: Canada 15-Year Perspective for Real World Evidence
Solutions by Component - Percentage Breakdown of Value Sales
for Data Sets and Services for the Years 2012, 2018 & 2027

Table 31: Canada Current & Future Analysis for Real World
Evidence Solutions by End-Use - Pharmaceutical & Medical Device
Companies, Healthcare Payers, Healthcare Providers and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2018 through 2027

Table 32: Canada Historic Review for Real World Evidence
Solutions by End-Use - Pharmaceutical & Medical Device
Companies, Healthcare Payers, Healthcare Providers and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2017

Table 33: Canada 15-Year Perspective for Real World Evidence
Solutions by End-Use - Percentage Breakdown of Value Sales for
Pharmaceutical & Medical Device Companies, Healthcare Payers,
Healthcare Providers and Other End-Uses for the Years 2012,
2018 & 2027

JAPAN
Table 34: Japan Current & Future Analysis for Real World
Evidence Solutions by Component - Data Sets and Services -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 35: Japan Historic Review for Real World Evidence
Solutions by Component - Data Sets and Services Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 36: Japan 15-Year Perspective for Real World Evidence
Solutions by Component - Percentage Breakdown of Value Sales
for Data Sets and Services for the Years 2012, 2018 & 2027

Table 37: Japan Current & Future Analysis for Real World
Evidence Solutions by End-Use - Pharmaceutical & Medical Device
Companies, Healthcare Payers, Healthcare Providers and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2018 through 2027

Table 38: Japan Historic Review for Real World Evidence
Solutions by End-Use - Pharmaceutical & Medical Device
Companies, Healthcare Payers, Healthcare Providers and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2017

Table 39: Japan 15-Year Perspective for Real World Evidence
Solutions by End-Use - Percentage Breakdown of Value Sales for
Pharmaceutical & Medical Device Companies, Healthcare Payers,
Healthcare Providers and Other End-Uses for the Years 2012,
2018 & 2027

CHINA
Table 40: China Current & Future Analysis for Real World
Evidence Solutions by Component - Data Sets and Services -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 41: China Historic Review for Real World Evidence
Solutions by Component - Data Sets and Services Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 42: China 15-Year Perspective for Real World Evidence
Solutions by Component - Percentage Breakdown of Value Sales
for Data Sets and Services for the Years 2012, 2018 & 2027

Table 43: China Current & Future Analysis for Real World
Evidence Solutions by End-Use - Pharmaceutical & Medical Device
Companies, Healthcare Payers, Healthcare Providers and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2018 through 2027

Table 44: China Historic Review for Real World Evidence
Solutions by End-Use - Pharmaceutical & Medical Device
Companies, Healthcare Payers, Healthcare Providers and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2017

Table 45: China 15-Year Perspective for Real World Evidence
Solutions by End-Use - Percentage Breakdown of Value Sales for
Pharmaceutical & Medical Device Companies, Healthcare Payers,
Healthcare Providers and Other End-Uses for the Years 2012,
2018 & 2027

EUROPE
Market Facts & Figures
European Real World Evidence Solutions Market: Competitor
Market Share Scenario (in %) for 2018 & 2027
Market Analytics
Table 46: Europe Current & Future Analysis for Real World
Evidence Solutions by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2018 through 2027

Table 47: Europe Historic Review for Real World Evidence
Solutions by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2017

Table 48: Europe 15-Year Perspective for Real World Evidence
Solutions by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2012, 2018 & 2027

Table 49: Europe Current & Future Analysis for Real World
Evidence Solutions by Component - Data Sets and Services -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 50: Europe Historic Review for Real World Evidence
Solutions by Component - Data Sets and Services Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 51: Europe 15-Year Perspective for Real World Evidence
Solutions by Component - Percentage Breakdown of Value Sales
for Data Sets and Services for the Years 2012, 2018 & 2027

Table 52: Europe Current & Future Analysis for Real World
Evidence Solutions by End-Use - Pharmaceutical & Medical Device
Companies, Healthcare Payers, Healthcare Providers and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2018 through 2027

Table 53: Europe Historic Review for Real World Evidence
Solutions by End-Use - Pharmaceutical & Medical Device
Companies, Healthcare Payers, Healthcare Providers and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2017

Table 54: Europe 15-Year Perspective for Real World Evidence
Solutions by End-Use - Percentage Breakdown of Value Sales for
Pharmaceutical & Medical Device Companies, Healthcare Payers,
Healthcare Providers and Other End-Uses for the Years 2012,
2018 & 2027

FRANCE
Table 55: France Current & Future Analysis for Real World
Evidence Solutions by Component - Data Sets and Services -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 56: France Historic Review for Real World Evidence
Solutions by Component - Data Sets and Services Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 57: France 15-Year Perspective for Real World Evidence
Solutions by Component - Percentage Breakdown of Value Sales
for Data Sets and Services for the Years 2012, 2018 & 2027

Table 58: France Current & Future Analysis for Real World
Evidence Solutions by End-Use - Pharmaceutical & Medical Device
Companies, Healthcare Payers, Healthcare Providers and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2018 through 2027

Table 59: France Historic Review for Real World Evidence
Solutions by End-Use - Pharmaceutical & Medical Device
Companies, Healthcare Payers, Healthcare Providers and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2017

Table 60: France 15-Year Perspective for Real World Evidence
Solutions by End-Use - Percentage Breakdown of Value Sales for
Pharmaceutical & Medical Device Companies, Healthcare Payers,
Healthcare Providers and Other End-Uses for the Years 2012,
2018 & 2027

GERMANY
Table 61: Germany Current & Future Analysis for Real World
Evidence Solutions by Component - Data Sets and Services -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 62: Germany Historic Review for Real World Evidence
Solutions by Component - Data Sets and Services Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 63: Germany 15-Year Perspective for Real World Evidence
Solutions by Component - Percentage Breakdown of Value Sales
for Data Sets and Services for the Years 2012, 2018 & 2027

Table 64: Germany Current & Future Analysis for Real World
Evidence Solutions by End-Use - Pharmaceutical & Medical Device
Companies, Healthcare Payers, Healthcare Providers and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2018 through 2027

Table 65: Germany Historic Review for Real World Evidence
Solutions by End-Use - Pharmaceutical & Medical Device
Companies, Healthcare Payers, Healthcare Providers and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2017

Table 66: Germany 15-Year Perspective for Real World Evidence
Solutions by End-Use - Percentage Breakdown of Value Sales for
Pharmaceutical & Medical Device Companies, Healthcare Payers,
Healthcare Providers and Other End-Uses for the Years 2012,
2018 & 2027

ITALY
Table 67: Italy Current & Future Analysis for Real World
Evidence Solutions by Component - Data Sets and Services -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 68: Italy Historic Review for Real World Evidence
Solutions by Component - Data Sets and Services Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 69: Italy 15-Year Perspective for Real World Evidence
Solutions by Component - Percentage Breakdown of Value Sales
for Data Sets and Services for the Years 2012, 2018 & 2027

Table 70: Italy Current & Future Analysis for Real World
Evidence Solutions by End-Use - Pharmaceutical & Medical Device
Companies, Healthcare Payers, Healthcare Providers and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2018 through 2027

Table 71: Italy Historic Review for Real World Evidence
Solutions by End-Use - Pharmaceutical & Medical Device
Companies, Healthcare Payers, Healthcare Providers and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2017

Table 72: Italy 15-Year Perspective for Real World Evidence
Solutions by End-Use - Percentage Breakdown of Value Sales for
Pharmaceutical & Medical Device Companies, Healthcare Payers,
Healthcare Providers and Other End-Uses for the Years 2012,
2018 & 2027

UNITED KINGDOM
Table 73: UK Current & Future Analysis for Real World Evidence
Solutions by Component - Data Sets and Services - Independent
Analysis of Annual Sales in US$ Million for the Years 2018
through 2027

Table 74: UK Historic Review for Real World Evidence Solutions
by Component - Data Sets and Services Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2017

Table 75: UK 15-Year Perspective for Real World Evidence
Solutions by Component - Percentage Breakdown of Value Sales
for Data Sets and Services for the Years 2012, 2018 & 2027

Table 76: UK Current & Future Analysis for Real World Evidence
Solutions by End-Use - Pharmaceutical & Medical Device
Companies, Healthcare Payers, Healthcare Providers and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2018 through 2027

Table 77: UK Historic Review for Real World Evidence Solutions
by End-Use - Pharmaceutical & Medical Device Companies,
Healthcare Payers, Healthcare Providers and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2017

Table 78: UK 15-Year Perspective for Real World Evidence
Solutions by End-Use - Percentage Breakdown of Value Sales for
Pharmaceutical & Medical Device Companies, Healthcare Payers,
Healthcare Providers and Other End-Uses for the Years 2012,
2018 & 2027

REST OF EUROPE
Table 79: Rest of Europe Current & Future Analysis for Real
World Evidence Solutions by Component - Data Sets and Services -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 80: Rest of Europe Historic Review for Real World
Evidence Solutions by Component - Data Sets and Services
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2017

Table 81: Rest of Europe 15-Year Perspective for Real World
Evidence Solutions by Component - Percentage Breakdown of Value
Sales for Data Sets and Services for the Years 2012, 2018 &
2027

Table 82: Rest of Europe Current & Future Analysis for Real
World Evidence Solutions by End-Use - Pharmaceutical & Medical
Device Companies, Healthcare Payers, Healthcare Providers and
Other End-Uses - Independent Analysis of Annual Sales in US$
Million for the Years 2018 through 2027

Table 83: Rest of Europe Historic Review for Real World
Evidence Solutions by End-Use - Pharmaceutical & Medical Device
Companies, Healthcare Payers, Healthcare Providers and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2017

Table 84: Rest of Europe 15-Year Perspective for Real World
Evidence Solutions by End-Use - Percentage Breakdown of Value
Sales for Pharmaceutical & Medical Device Companies, Healthcare
Payers, Healthcare Providers and Other End-Uses for the Years
2012, 2018 & 2027

ASIA-PACIFIC
Table 85: Asia-Pacific Current & Future Analysis for Real World
Evidence Solutions by Component - Data Sets and Services -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 86: Asia-Pacific Historic Review for Real World Evidence
Solutions by Component - Data Sets and Services Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 87: Asia-Pacific 15-Year Perspective for Real World
Evidence Solutions by Component - Percentage Breakdown of Value
Sales for Data Sets and Services for the Years 2012, 2018 &
2027

Table 88: Asia-Pacific Current & Future Analysis for Real World
Evidence Solutions by End-Use - Pharmaceutical & Medical Device
Companies, Healthcare Payers, Healthcare Providers and Other
End-Uses - Independent Analysis of Annual Sales in US$ Million
for the Years 2018 through 2027

Table 89: Asia-Pacific Historic Review for Real World Evidence
Solutions by End-Use - Pharmaceutical & Medical Device
Companies, Healthcare Payers, Healthcare Providers and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2017

Table 90: Asia-Pacific 15-Year Perspective for Real World
Evidence Solutions by End-Use - Percentage Breakdown of Value
Sales for Pharmaceutical & Medical Device Companies, Healthcare
Payers, Healthcare Providers and Other End-Uses for the Years
2012, 2018 & 2027

REST OF WORLD
Table 91: Rest of World Current & Future Analysis for Real
World Evidence Solutions by Component - Data Sets and Services -
Independent Analysis of Annual Sales in US$ Million for the
Years 2018 through 2027

Table 92: Rest of World Historic Review for Real World Evidence
Solutions by Component - Data Sets and Services Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2017

Table 93: Rest of World 15-Year Perspective for Real World
Evidence Solutions by Component - Percentage Breakdown of Value
Sales for Data Sets and Services for the Years 2012, 2018 &
2027

Table 94: Rest of World Current & Future Analysis for Real
World Evidence Solutions by End-Use - Pharmaceutical & Medical
Device Companies, Healthcare Payers, Healthcare Providers and
Other End-Uses - Independent Analysis of Annual Sales in US$
Million for the Years 2018 through 2027

Table 95: Rest of World Historic Review for Real World Evidence
Solutions by End-Use - Pharmaceutical & Medical Device
Companies, Healthcare Payers, Healthcare Providers and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2017

Table 96: Rest of World 15-Year Perspective for Real World
Evidence Solutions by End-Use - Percentage Breakdown of Value
Sales for Pharmaceutical & Medical Device Companies, Healthcare
Payers, Healthcare Providers and Other End-Uses for the Years
2012, 2018 & 2027

IV. COMPETITION
Total Companies Profiled: 41
Read the full report: https://www.reportlinker.com/p05959864/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001